Role of circulating white blood cells in the enhancement of antigen-induced bronchoconstriction after intravascular complement activation with cobra venom factor.
Regal
J F
JF
Department of Pharmacology, University of Minnesota, Duluth 55812-2487.
Fraser
D G
DG
D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D016084:Bronchoconstriction / Q000187:drug effects / Q000502:physiology*; D003167:Complement Activation / Q000187:drug effects*; D004546:Elapid Venoms / Q000494:pharmacology*; D006168:Guinea Pigs; D007958:Leukocyte Count / Q000187:drug effects; D007962:Leukocytes / Q000187:drug effects / Q000502:physiology*; D010047:Ovalbumin / Q000008:administration & dosage; D010976:Platelet Count / Q000187:drug effects; D012129:Respiratory Function Tests
D000941:Antigens; D004546:Elapid Venoms; C016310:cobra venom factor; D010047:Ovalbumin